Ruxolitinib, a Janus kinase inhibitor, is associated with severe withdrawal phenomena. Adequate tapering is often underemphasized in surgical emergencies and can complicate the postoperative course. We present a case of acute ruxolitinib withdrawal in a gentleman undergoing emergency cardiac surgery.
|Number of pages||3|
|Journal||Interactive Cardiovascular and Thoracic Surgery|
|Publication status||Published - Jul 2022|
- Aortic syndrome
- Cardiac surgery